Great pipeline, amazing scientists and honest leadership. Great HR, and higher-ups are always looking to help junior folks grow.
Cons
No cons to think of
1
1.0
31 Oct 2025
Anonymous employee
Current employee, more than 3 years
Recommend
CEO approval
Business outlook
Pros
Had promise a few years ago. Smart and good people. leadership was supportive of the teams and the strategy and vision was focused on leveraging the platform to advance drug discovery. Employees were motivated and working together towards exciting goals.
Cons
Greed and impatience have made the exec leaders dismiss opportunities to stand out and differentiate and talented individuals and teams are undervalued. Many execs have no biotech experience, are focused on themselves getting rich quick and have lost interest in being engaged leaders and holding themselves and other leaders accountable. Clinging on to the AI hype while they still can, but lacking vision to realize the company’s early promise. The culture has tanked and people are disillusioned. Bad behavior is rewarded and nothing changes to improve culture despite lip service. The pay is good but not worth the burn out and bad culture.
1
Generate:Biomedicines Response
7mo
Thank you for sharing your perspectives. I’m sorry to hear this has been your experience, and I would very much welcome a confidential conversation to learn more about your observations and suggestions. I encourage you to reach out to me (or anyone on the People & Culture team), at any time, to discuss. I would welcome that engagement.
-Beth Grous, Chief People Officer